A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models.
about
Isothiocyanates Are Promising Compounds against Oxidative Stress, Neuroinflammation and Cell Death that May Benefit Neurodegeneration in Parkinson's DiseaseA novel synthetic isothiocyanate ITC-57 displays antioxidant, anti-inflammatory, and neuroprotective properties in a mouse Parkinson's disease model.Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.Neuroprotective Effects and Mechanisms of Action of Multifunctional Agents Targeting Free Radicals, Monoamine Oxidase B and Cholinesterase in Parkinson's Disease Model.
P2860
A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
A Novel Compound ITC-3 Activat ...... in Parkinson's Disease Models.
@en
A Novel Compound ITC-3 Activat ...... in Parkinson's Disease Models.
@nl
type
label
A Novel Compound ITC-3 Activat ...... in Parkinson's Disease Models.
@en
A Novel Compound ITC-3 Activat ...... in Parkinson's Disease Models.
@nl
prefLabel
A Novel Compound ITC-3 Activat ...... in Parkinson's Disease Models.
@en
A Novel Compound ITC-3 Activat ...... in Parkinson's Disease Models.
@nl
P2093
P2860
P1476
A Novel Compound ITC-3 Activat ...... in Parkinson's Disease Models.
@en
P2093
Dong Jin Kim
Hye Ri Kim
Hyo Jin Son
Ji Hyun Kim
Ki Duk Park
Onyou Hwang
Se Hee Han
P2860
P2888
P304
P356
10.1007/S12640-015-9550-Z
P577
2015-08-02T00:00:00Z